Inozyme Pharma, Inc. SC 13D and SC 13D/A reports

Location
321 Summer Street, Suite 400, Boston, MA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/5/2024, 08:34 AM
Form type Sec Links Description Filing date Reporting date
SC 13D/A Report SC 13D/A Feb 20, 2024
SC 13D/A Report SC 13D/A Feb 12, 2024
SC 13D/A Report SC 13D/A Aug 11, 2023
SC 13D/A Report SC 13D/A Aug 8, 2023
SC 13D/A Report SC 13D/A May 23, 2023
SC 13D/A Report SC 13D/A Apr 4, 2023
SC 13D Report SC 13D Apr 28, 2022
SC 13D/A Report SC 13D/A Apr 28, 2022
SC 13D/A Report SC 13D/A Jul 30, 2021
SC 13D/A Report SC 13D/A Mar 30, 2021
SC 13D Report SCHEDULE 13D Mar 4, 2021
SC 13D/A Report SC 13D - AMENDMENT NO. 2 Feb 1, 2021
SC 13D/A Report SC 13D/A Oct 5, 2020
SC 13D Report SC 13D Aug 7, 2020
SC 13D Report SC 13D Aug 4, 2020
SC 13D Report SC 13D Jul 29, 2020